Bolt Biotherapeutics Inc. (NASDAQ: BOLT)
$0.74
+0.0064 ( +0.87% ) 97.8K
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
Market Data
Open
$0.74
Previous close
$0.73
Volume
97.8K
Market cap
$28.22M
Day range
$0.73 - $0.74
52 week range
$0.71 - $1.56
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Nov 09, 2023 |
10-q | Quarterly Reports | 61 | Aug 07, 2023 |
8-k | 8K-related | 14 | Aug 07, 2023 |